AVEO PHARMACEUTICALS INC | Business Contracts

Agreement and Plan of Merger, dated October 18, 2022, by and among AVEO Pharmaceuticals, Inc., LG Chem, Ltd. and Acacia Acquisition Sub, Inc (Filed With SEC on October 18, 2022)

Revocable Temporary License Agreement, dated November 17, 2021, by and between the Registrant and Commonwealth Care Alliance, Inc (Filed With SEC on March 14, 2022)

First Amendment to Sublease Agreement, dated November 17, 2021, by and between the Registrant and Commonwealth Care Alliance, Inc (Filed With SEC on March 14, 2022)

Third Amendment to Amended and Restated Loan and Security Agreement, dated March 8, 2022, by and among the Registrant, the several banks and other financial institutions or... (Filed With SEC on March 14, 2022)

Form of Non-Competition and Non-Solicitation Agreement, dated March (Filed With SEC on March 14, 2022)

Offer Letter by the Registrant to Jebediah Ledell, dated November 12, 2021 (Filed With SEC on March 14, 2022)

Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement, dated January 26, 2021, by and between the Registrant and Bristol-Myers Squibb Company (Filed With SEC on May 10, 2021)

License Agreement, dated December 18, 2015, by and between the Registrant and EUSA Pharma (UK) Limited (Filed With SEC on March 14, 2022)

Executive Severance and Change in Control Plan (Filed With SEC on March 14, 2022)

Severance and Change in Control Agreement, dated December 1, 2021, by and between the Registrant and Jebediah Ledell (Filed With SEC on March 14, 2022)

Severance and Change in Control Agreement, dated March 10, 2021, by and between the Registrant and Michael Ferraresso (Filed With SEC on March 14, 2022)

Offer Letter by the Registrant to Michael Ferraresso, dated April 8, 2021 (Filed With SEC on March 14, 2022)

Amended and Restated License Agreement, dated August 13, 2015, by and between the Registrant and St. Vincents Hospital Sydney Limited (Filed With SEC on November 8, 2021)

Termination, Separation and Release of Claims Agreement, dated August 27, 2021, by and between AVEO Pharmaceuticals, Inc. and Michael Needle, M.D (Filed With SEC on August 27, 2021)

Clinical Trial Collaboration and Supply Agreement, dated January 23, 2021, by and between the Registrant and Bristol-Myers Squibb Company (Filed With SEC on May 10, 2021)

Underwriting Agreement, dated March 23, 2021, by and among the Company, SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on March 24, 2021)

Amendment No. 1 to Option and License Agreement, dated as of March 18, 2014 by and between the Registrant and Biogen Idec MA Inc (Filed With SEC on March 16, 2021)

Option and License Agreement, dated as of March 18, 2009, by and between the Registrant and Biogen Idec International GmbH (Filed With SEC on March 16, 2021)

Second Amendment to Amended and Restated Loan and Security Agreement, dated February 1, 2021, by and among AVEO Pharmaceuticals, Inc., the several banks and other financial... (Filed With SEC on February 2, 2021)

Separation and Release of Claims Agreement, dated January 25, 2021, by and between AVEO Pharmaceuticals, Inc. and Karuna Rubin (Filed With SEC on January 29, 2021)

First Amendment to Amended and Restated Loan and Security Agreement, dated as of August 7, 2020, by and among the registrant, Hercules Capital, Inc. and the other lenders named... (Filed With SEC on August 10, 2020)

Underwriting Agreement, dated June 16, 2020, by and among the Company, SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on June 17, 2020)

Sublease, dated March 5, 2020, by and between the Registrant and Commonwealth Care Alliance, Inc (Filed With SEC on April 30, 2020)

Severance and Change in Control Agreement, dated January 6, 2020, by and between the Registrant and Erick Lucera (Filed With SEC on March 16, 2020)

Offer Letter by and between the Registrant and Erick Lucera, dated December 12, 2019 (Filed With SEC on March 16, 2020)

Description of Registered Securities (Filed With SEC on March 16, 2020)

Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on March 16, 2020)

Amendment to License Agreement, dated as of August 1, 2019, by and between AVEO and KKC (Filed With SEC on August 1, 2019)

Form of Warrant (Filed With SEC on April 4, 2019)

Purchase Agreement, dated April 3, 2019, by and between AVEO Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on April 4, 2019)

Severance and Change in Control Agreement, dated March 13, 2019, by and between the Registrant and Karuna Rubin (Filed With SEC on March 14, 2019)

Agreement, dated December 18, 2018, by and between the Registrant and Novartis International Pharmaceutical Ltd (Filed With SEC on March 14, 2019)

Offer Letter by and between the Registrant and Karuna Rubin dated June 16, 2015 (Filed With SEC on March 14, 2019)

AVEO PHARMACEUTICALS INC (33)